Privia Health Group, Inc.PRVANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.55% | +15.62% | +23.40% | +32.54% | +17.42% |
| Gross Profit Growth | +22.86% | +12.02% | +11.66% | +34.51% | -2.02% |
| EBITDA Growth | +121.80% | +169.25% | +20.40% | +155.45% | +126.38% |
| Operating Income Growth | +269.58% | +534.02% | -34.56% | +147.77% | +114.90% |
| Net Income Growth | +55.00% | +41.42% | -22.50% | +94.09% | +108.02% |
| EPS Growth | +83.00% | +0.00% | -26.67% | +86.33% | +103.01% |
| EPS Diluted Growth | +74.00% | +50.00% | -30.33% | +77.67% | +101.72% |
| Weighted Average Shares Growth | +1.72% | +1.79% | +2.37% | +2.60% | +2.54% |
| Weighted Average Shares Diluted Growth | +1.27% | +2.16% | +2.50% | +2.41% | +3.12% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +16.69% | +0.00% | -76.87% | +56.83% | +70.46% |
| Free Cash Flow Growth | +16.73% | +0.00% | -76.87% | +53.21% | +70.46% |
| Receivables Growth | +8.74% | +12.32% | +19.98% | +22.03% | +126695.90% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +13.59% | +14.73% | +18.09% | +17.93% | +120466.87% |
| Book Value per Share Growth | +11.23% | +12.32% | +12.03% | +12.40% | +113088.07% |
| Debt Growth | -32.56% | -27.65% | -1.69% | +0.94% | +170400.89% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +14.05% | +1.14% | +23.92% | +23.47% | +87262.73% |